Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 4
1974 2
1975 1
1976 3
1977 2
1978 6
1979 14
1980 6
1981 1
1982 3
1983 13
1984 4
1985 12
1986 39
1987 9
1988 15
1989 16
1990 15
1991 26
1992 14
1993 30
1994 20
1995 14
1996 43
1997 16
1998 31
1999 28
2000 29
2001 20
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Cancer and thrombosis.
Donati MB. Donati MB. Haemostasis. 1994 Mar-Apr;24(2):128-31. doi: 10.1159/000217092. Haemostasis. 1994. PMID: 7959360 Review.
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. ...Recently, emphasis has been given to the potential risk of cancer therapy (both surgery and chemotherapy) in enhancing the risk for thromboembolic diseas …
Thrombosis is the most frequent complication and the second cause of death in patients with overt malignant disease. ...Recently, emp …
Pathogenesis of thrombosis.
Prentice CR. Prentice CR. Haemostasis. 1990;20 Suppl 1:50-9. doi: 10.1159/000216161. Haemostasis. 1990. PMID: 2083873 Review.
The pathogenesis of thrombosis involves consideration of two processes: atherosclerosis and thrombosis. ...In veins the atherosclerotic process does not occur, and thrombosis is precipitated by immobility often associated with accidental or surgical trauma. . …
The pathogenesis of thrombosis involves consideration of two processes: atherosclerosis and thrombosis. ...In veins the athero …
Neutrophils and deep venous thrombosis.
Stewart GJ. Stewart GJ. Haemostasis. 1993 Mar;23 Suppl 1:127-40. doi: 10.1159/000216922. Haemostasis. 1993. PMID: 8495864 Review.
A case can be made for the participation of polymorphonuclears (PMN) in the initiation and propagation of venous thrombosis. In animal models leukocytes adhered to areas of veins that serve as sites for initiation of thrombi in patients. ...Lidocaine and one of its derivat …
A case can be made for the participation of polymorphonuclears (PMN) in the initiation and propagation of venous thrombosis. In anima …
Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient.
Ray JG, Burows RF, Ginsberg JS, Burrows EA. Ray JG, et al. Haemostasis. 2000 May-Jun;30(3):103-17. doi: 10.1159/000022532. Haemostasis. 2000. PMID: 11014960 Review.
The likely cause of death among patients with paroxysmal nocturnal hemoglobinuria was described in nine studies: 22.2% of fatalities were due to venous thrombosis (95% CI 11.8-38.0), more commonly in western countries (event rate 37.2%, 95% CI 21.6-56.0). ...CONCLUSION: In …
The likely cause of death among patients with paroxysmal nocturnal hemoglobinuria was described in nine studies: 22.2% of fatalities were du …
Plaque rupture, thrombosis, and therapeutic implications.
Fuster V, Badimon J, Chesebro JH, Fallon JT. Fuster V, et al. Haemostasis. 1996 Oct;26 Suppl 4:269-84. doi: 10.1159/000217308. Haemostasis. 1996. PMID: 8979133 Review.
In this brief presentation, we outline 1) Definition of Atherosclerotic Lesions: eight morphologically different lesions are defined (Type I to VI) in various phases of disease. 2) Vulnerable Lipid-Rich Plaques and the ACS: The type IV and Va lesions tend to be relatively small i …
In this brief presentation, we outline 1) Definition of Atherosclerotic Lesions: eight morphologically different lesions are defined (Type I …
Standardization of plasminogen assays.
Gaffney PJ. Gaffney PJ. Haemostasis. 1988;18 Suppl 1:47-60. doi: 10.1159/000215837. Haemostasis. 1988. PMID: 3280425 Review.
Plasmin potency estimates. Influence of substrate used in assay. Thrombosis and Haemostasis 1981, 45, 107-109). Activation procedures of plasminogen and subsequent assays of plasmin using a variety of substrates have been recently superseded by an assay which involves the …
Plasmin potency estimates. Influence of substrate used in assay. Thrombosis and Haemostasis 1981, 45, 107-109). Activation procedures …
Heparin-induced thrombocytopenia.
Kelton JG. Kelton JG. Haemostasis. 1986;16(2):173-86. doi: 10.1159/000215288. Haemostasis. 1986. PMID: 3519379 Review.
Finally, a small subset of patients with heparin-induced thrombocytopenia develop the disastrous complication of heparin-induced thrombocytopenia plus arterial thrombosis. Some of these patients die. In this review, we will summarize some of the issues concerning heparin-i …
Finally, a small subset of patients with heparin-induced thrombocytopenia develop the disastrous complication of heparin-induced thrombocyto …
Antiphospholipid-thrombosis syndromes.
Bick RL, Arun B, Frenkel EP. Bick RL, et al. Haemostasis. 1999;29(2-3):100-10. doi: 10.1159/000022492. Haemostasis. 1999. PMID: 10629391 Review.
Antiphospholipid antibodies are strongly associated with thrombosis and appear to be the most common of the acquired blood protein defects causing thrombosis. Based upon our experience, approximately 25% of patients with unexplained venous thrombosis, approxi …
Antiphospholipid antibodies are strongly associated with thrombosis and appear to be the most common of the acquired blood protein de …
Venous thrombosis: prevalence and interaction of risk factors.
Rosendaal FR. Rosendaal FR. Haemostasis. 1999 Dec;29 Suppl S1:1-9. doi: 10.1159/000054106. Haemostasis. 1999. PMID: 10629398 Review.
The key to understanding why certain individuals develop deep vein thrombosis at varying times, despite similar risk factors being present, is the realization of the importance of gene-gene and gene-environment interactions between risk factors. The discovery of factor V L …
The key to understanding why certain individuals develop deep vein thrombosis at varying times, despite similar risk factors being pr …
Regulation of megakaryocytopoiesis.
Caen JP, Han ZC, Bellucci S, Alemany M. Caen JP, et al. Haemostasis. 1999 Sep;29(1):27-40. doi: 10.1159/000022458. Haemostasis. 1999. PMID: 10494032 Review.
A potential limiting side-effect of TPO could be the induction of thrombosis. Nevertheless, it is too early to know whether this cytokine will be of major therapeutic importance for patients with life-threatening thrombocytopenia, such as patients undergoing bone marrow tr …
A potential limiting side-effect of TPO could be the induction of thrombosis. Nevertheless, it is too early to know whether this cyto …
437 results